A61K 33/243
Platinum
Official title: Platinum; Compounds thereof
A61K33/243 (Platinum) appears on 1,729 US grants and 3,252 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,729
- Published applications
- 3,252
- Assignees
- 1,497
- Inventors
- 6,086
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 4 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 6 | 0 |
| 1991 | 6 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 15 | 0 |
| 1998 | 12 | 0 |
| 1999 | 17 | 0 |
| 2000 | 28 | 0 |
| 2001 | 23 | 16 |
| 2002 | 22 | 38 |
| 2003 | 22 | 71 |
| 2004 | 22 | 67 |
| 2005 | 14 | 52 |
| 2006 | 15 | 82 |
| 2007 | 11 | 55 |
| 2008 | 14 | 74 |
| 2009 | 14 | 63 |
| 2010 | 31 | 84 |
| 2011 | 45 | 99 |
| 2012 | 37 | 81 |
| 2013 | 50 | 136 |
| 2014 | 71 | 167 |
| 2015 | 79 | 156 |
| 2016 | 103 | 197 |
| 2017 | 100 | 198 |
| 2018 | 93 | 178 |
| 2019 | 136 | 206 |
| 2020 | 106 | 204 |
| 2021 | 122 | 213 |
| 2022 | 101 | 199 |
| 2023 | 96 | 174 |
| 2024 | 111 | 187 |
| 2025 | 91 | 152 |
| 2026 | 70 | 103 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Piperidine urea derivatives for cancer therapy15 Sep 2026US 12,734,164 B2NeuroPn Therapeutics, Inc.
- Cell therapeutic agent for cancer treatment and combination therapy with same15 Sep 2026US 12,735,680 B2Cell & Brain Co., Ltd
- Anticancer adjuvant and pharmaceutical composition for treating anticancer-agent-resistant cancer, and kit comprising same15 Sep 2026US 12,735,704 B2Dong-A University Research Foundation for Industry-Academy Cooperation
- Methods of treating breast cancer15 Sep 2026US 12,738,355 B2City of Hope
- Methods of treating lung cancer with a PD-1 axis binding antagonist, a platinum agent, and a topoisomerase II inhibitor8 Sep 2026US 12,728,162 B2Genentech, Inc.
- Liposome compositions and medical uses thereof8 Oct 2026US 2026/0306404 A1
- Combination treatment with cisplatin and pg3 for p53-mutated head and neck cancers8 Oct 2026US 2026/0306450 A1Brown University
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
- A combination therapy for cancer treatment8 Oct 2026US 2026/0306633 A1Purdue Research Foundation
- Sirt1 inhibitor or antagonist for use in preventing and/or treating an hpv induced tumour1 Oct 2026US 2026/0294868 A1Universita Degli Studi Del Piemonte Orientale “A. Avogadro”
Most cited
By later US patents
- Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders222US 7,763,420 B2Genelux Corporation · 2010
- Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies166US 6,949,245 B1Genentech, Inc. · 2005
- Antitumor agent effect enhancer containing IL-6 antagonist146US 6,086,874 AChugai Seiyaku Kabushiki Kaisha · 2000
- Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same145US 6,217,866 B1Rhone-Poulenc Rorer International (Holdings) Inc. · 2001
- Biodegradable implant and a method for preparation thereof140US 4,612,009 ACeskoslovenska akademie ved · 1986